Posted on Leave a comment

A Must listener – Stephen McMahon at PRF

Musings on the Progress of Pain Research: A Podcast with Stephen McMahon

 

You could spend 45 minutes in a whole bunch of worse ways…
“McMahon discusses his early days in the pain research field, what it was like to train with Patrick Wall, the gate control theory of pain, central sensitization, and much more”

“Not the smartness of people but the smartness of nature, I still think that there are many thinks to be discovered from the natural world that would greatly help in our efforts to develop analgesics”

 

Stephen McMahon

 

Go to Podcast here

About Stephen McMahon

In this third IASP podcast features pioneering pain researcher Stephen McMahon, PhD. Dr. McMahon is Sherrington Professor of Physiology at King’s College London, UK, where he leads a research group in clinical neuroscience. He also directs the Wellcome Trust Pain Consortium, an international network of leading pain researchers. He trained under Patrick Wall at University College London before moving to King’s College London in 1985 to run his own lab. His major research interest is pain mechanisms, and he has been working to identify and understand pain mediators. More recently, he has focused on neuroimmune interactions and the role of genetics and epigenetics in pain.

Posted on Leave a comment

Meet Dr. Kirsty Bannister

Kirsty Bannister

Biography

I lead the Bannister lab group, where we focus on the biological, pharmacological and anatomical basis of pain pathways and their plasticity in chronic pain states. Chronic pain affects up to 20% of the adult population and can occur in the presence or absence of any past injury or evidence of body damage. Modules that I teach on include Physiology and Pharmacology of the Central Nervous System, Pharmacology of Neurological and Psychiatric Disorders, Core Year One Fundamentals of Pharmacology, and Neuroscience. My lab’s research is funded by the Academy of Medical Sciences and the NC3Rs.

Please see my Research Staff Profile for more detail

Posted on Leave a comment

Central Nervous System Targets: Supraspinal Mechanisms of Analgesia

Central Nervous System Targets: Supraspinal Mechanisms of Analgesia

In the run up to Dr Kirsty Bannister’s Home Brew we will be sharing her work with you!

Pain care needs to understand and be able to integrate current discoveries in lab-based science.

Check out this article and drop your thoughts in the comments!
“Central Nervous System Targets: Supraspinal Mechanisms of Analgesia”

https://lnkd.in/etmcssz

Posted on Leave a comment

Discovering novel & effective pain treatments

About the event

We are SO excited to welcome Dr. Kirsty Bannister to Le Pub

Kirsty will be talking about the reality of discovering novel and effective pain-relieving treatments through performing bench to beside translational research.

Chronic pain affects up to 20% of the adult population and can occur in the presence or absence of any past injury or evidence of body damage. ‘Nothing is more unique than our experience of pain and the idea that the same stimulus could evoke a different pain sensation in different individuals has always fascinated me’.

‘There have been great improvements in our understanding of pain physiology and pathophysiology over the years, but why hasn’t this translated to a met clinical analgesic need? By discussing the ways in which we currently assess nociception and pain in non-human and human experimental models, we will slowly unravel the intricacies and challenges of treating persistent pain in varied patient groups’.

This is going to be an incredible Le Pub Homebrew!

World Event Times

London, Thursday, 18 March 2021, 20:00 GMT

Amsterdam, Thursday, 18 March 2021, 21:00 CET

New York, Thursday, 18 March 2021, 16:00 EDT

Dr. Kirsty Bannister

Kirsty Bannister is a Lecturer in the Institute of Psychiatry, Psychology and Neuroscience at Guy’s campus, King’s College London. Kirsty does research in neuropharmacology.

Kirsty leads the Bannister lab group, where she focuses on the biological, pharmacological and anatomical basis of pain pathways and their plasticity in chronic pain states. Modules that she teaches on include Physiology and Pharmacology of the Central Nervous System, Pharmacology of Neurological and Psychiatric Disorders, Core Year One Fundamentals of Pharmacology, and Neuroscience.

Cancellation Terms

Places can be cancelled and refunded up to 48 hours before the start of the event. Within 48 hours of start time no refund.

Recordings

Please note that Le Pub Home Brew is a LIVE EVENT. We are looking at options for giving access to recordings in the future, but right now, we are doing what we are best at – bringing you awesome live and interactive learning events!

Kirsty Bannister Efic interview with Morten Hoegh

Posted on Leave a comment

Find out when exercise will help or hinder when you’re experiencing pain

Find out when exercise will help or hinder when you're experiencing pain

About this event

Exercise is a recommended treatment for those with chronic pain. However, individuals with chronic pain have significant pain during activity that can interfere with exercise treatments. We will discuss the underlying neurobiology for how physical activity increases and decreases pain, the clinical implications of these findings, and how treatment with TENS can reduce movement-evoked pain.

World Event Times

London, Thursday, 18 February 2021, 20:00:00 GMT

Amsterdam, Thursday, 18 February 2021, 21:00:00 CET

New York, Thursday, 18 February 2021, 15:00:00 EST

Kathleen A. Sluka, PT, PhD, FAPTA

Professor of Physical Therapy and Rehabilitation Science

Dr. Sluka’s laboratory studies the peripheral and central mechanisms of chronic musculoskeletal pain, and non-pharmacological treatment for chronic pain. These studies involve the use of animal models of muscle pain developed and characterized in Dr. Sluka’s laboratory, as well as projects in human subjects. We use a variety of techniques to address these questions including cell culture, molecular biology, genetic manipulations, behavioral pharmacology, and standard clinical trial methodology. Our overall goals are to improve the management of pain for people with a variety of musculoskeletal pain conditions by discovering the underlying mechanisms that lead to the development of chronic pain, discovering new therapies for pain management, and improving the use of currently available treatment for pain.

Cancellation Terms

Places can be cancelled and refunded up to 48 hours before the start of the event. Within 48 hours of start time no refund.

Recordings

Please note that Le Pub Home Brew is a LIVE EVENT. We are looking at options for giving access to recordings in the future, but right now, we are doing what we are best at – bringing you awesome live and interactive learning events!

Posted on Leave a comment

Pain, hyperalgesia and activity in nociceptive C units in humans

Pain, hyperalgesia and activity in nociceptive C units in humans

Synopsis

Check out this great bit of work by LaMotte et al from 1992.
 
Here’s some simple reflections of the science:
 
– First they’re exploring activity of nociceptors in humans. That means someone volunteered for this!
– They use a crude way of ‘finding’ C-mechanoheat nociceptive units (CMHs) – scrape the skin or pinch it between the fingers
– It is only classified as a C-fibre if the conduction velocity is less than 2 m/s
– It is only classified as mechanoheat nociceptor if it selectively responds to technical or heat stimuli which typically cause pain
– They carefully map the receptive field
– Then they inject capsaicin i.e. the active component of chili peppers
– Interestingly, they tried to limit the numerical rating scale of pain to sensation only (is it possible to separate yourself from the unpleasantness or tolerability?)
 
What did they find?
– Heat and pain threshold reduced after injecting capsaicin. Now temperatures as low as 30C were felt as painful!
– Cooling the skin reduced pain and the spontaneous firing of the CMHs
– Warming increased this again!
– There was evidence of mechanical hyperalgesia i.e. increased pain to mechanical stimuli
– Some of this was outside of the skin zone affected by the injection i.e. ‘secondary hyperalgesia’
– There was evidence of analgesia around the injection site too
A simple summary:
– Ask a bunch of crazy people if it’s ok to inject some chili into them
– Scrape, pinch, electrically stimulate, heat and cool them whilst asking if it hurts
– Find that the injection makes these things simultaneously hurt more or less depending on where you do it
– Then discover something totally cool but keep in under wraps
Here’s the cool discovery – hang in there!
“A few presumably chemosensitive C units were discovered serendipitously during studies of CMH units….” In other words, it looks like these researchers were (?) the first to discover sleeping or silent nociceptors in humans. BOOM
It’s worth hearing their summary and considering some of the current proposed models to understand pain with.
“An interesting question is why pain from intradermal injection of [capsaicin] is so intense….One possible explanation might be that the discharge pattern in C polymodal nociceptors on capsaicin injection is irregular, with bursts of impulses …. It is conceivable that such high instantaneous firing rates during bursts of impulses could give rise to considerable pain due to temporal summation….It is also possible that several types of nociceptors are activated by capsaicin. Candidate nociceptors in addition to the CMHs could include purely chemosensitive units as well as the heat nociceptors that respond both to noxious heat and to capsaicin but not to mechanical or cold stimuli.”
 
Enjoy!

Research papers

You can access Lemotte’ paper here